Clinical Trials Directory

Trials / Unknown

UnknownNCT03594032

Prevalence and Characteristics of Patients With Bronchiectasis Comorbid Nontuberculous Mycobacteria

Prevalence and Clinical Characteristics of Patients With Bronchiectasis With Comorbid Nontuberculous Mycobacteria Among Middle-aged and Old Women

Status
Unknown
Phase
Study type
Observational
Enrollment
216 (estimated)
Sponsor
Bin Cao · Academic / Other
Sex
Female
Age
50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to Understand the prevalence of non-tuberculous mycobacterial(NTM) infections in the middle-aged and old women patients with bronchiectasis in Mainland China, and explore the characteristics of patients with bronchiectasis comorbid NTM.

Detailed description

The development of bronchiectasis is closely related to chronic infection of pathogenic microorganisms .Bronchiectasis and nontuberculous mycobacterial (NTM) infections are inextricably linked Pathophysiologically. But the incidence rate and characteristics of NTM infections among patients with bronchiectasis remains unclear in mainland China. In this study, we will collect data of participants about demographic ,co-morbidities ,spirometry, mMRC score ,exacerbation history, QOL-B questionnaire, aetiology, spirometry , HRCT(or CT) scan ,results of microbiology samples and treatments, collect three consecutive sputum(or induced sputum) samples to smear, bacteria culture, acid-fast stain, mycobacterium cultivation and identification, drug susceptibility testing of nontuberculous mycobacteria.To estimate the prevalance of non-tuberculous mycobacterial(NTM) infections in Middle-aged and old women patients with bronchiectasis in northern China. To analyze clinical manifestations and microbiological characteristics of patients with bronchiectasis comorbid NTM infections By 16SRNA and gene sequencing. In addition, A cross-sectional investigation about lung function and clinical data will be done among patients who have confirmed bronchiectasis with NTM from February 2017 to December 2020.

Conditions

Timeline

Start date
2018-08-14
Primary completion
2020-12-01
Completion
2021-08-01
First posted
2018-07-20
Last updated
2020-01-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03594032. Inclusion in this directory is not an endorsement.